UPDATE : Tuesday, October 15, 2019
상단여백
Hanmi marks ₩270.4 billion in Q2 sales by Lee Han-soo 2019-07-30 17:26
Kolmar Korea boosts beauty, health biz through acquisitions by Park Gi-taek 2019-07-30 14:43
GC’s Chinese partner applies for Hunter syndrome drug’s sales approval by Lee Han-soo 2019-07-30 10:49
‘FDA likely to OK 11 blockbuster candidates in August’ by Kim Yun-mi 2019-07-29 16:55
Top-30 makers produce more than half of drugs by Lee Hye-seon 2019-07-29 16:38
라인
Takeda’s Zejula poised to change local ovarian cancer treatment market by Kim Yun-mi 2019-07-29 12:04
Court extends ‘temporary suspension’ of order to cancel Invossa trials by Jeong Sae-im 2019-07-26 17:50
SNUBH professor is 1st Asian keynoter at international Alzheimer meet by Lee Han-soo 2019-07-26 16:08
‘Kolon Life Science to start following up on Invossa-treated patients’ by Lee Han-soo 2019-07-26 12:21
JW Creagene wins US patent for making dendritic cell treatment by Lee Han-soo 2019-07-25 16:39
라인
Merck, Pfizer launch metastatic merkel cell carcinoma treatment in Korea by Lee Han-soo 2019-07-25 15:18
[Focus] Korean biopharmas eye US Humira market by Jeong Sae-im 2019-07-25 15:02
Kolon Life Science ends Invossa deal with Hong Kong partner by Lee Han-soo 2019-07-25 11:17
Tecentriq 1st immunotherapy to get coverage regardless of PD-L1 expression by Lee Han-soo 2019-07-24 11:59
Alteogen to develop growth hormone for children with Brazilian partner by Lee Han-soo 2019-07-23 15:57
라인
Hanmi's US partner to expand Poziotinib clinical program by Lee Han-soo 2019-07-23 14:25
Merck Biopharma Korea names new general manager by Lee Han-soo 2019-07-23 11:08
‘Doubts about biopharmaceutical-developing ability to change investment pattern’ by By Jeong Sae-im 2019-07-23 10:58
Will Gilead enter the autoimmune diseases market? by Kim Yun-mi 2019-07-22 17:34
Korean drugs strong in anti-reflux treatment market by Jeong Sae-im 2019-07-22 15:15
여백
여백
여백
Back to Top